TYK MEDICINES
TYK Medicines, which has biological laboratories, cell culture laboratories, analysis laboratories, chemical analysis laboratories, and instrument analysis laboratories, is a drug research and development company. For inquiries, email, telephone numbers, and physical addresses are available on their website.
TYK MEDICINES
Industry:
Biotechnology Health Care Product Research
Founded:
2018-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.tykmedicines.com
Total Employee:
101+
Status:
Active
Contact:
021-31317178
Email Addresses:
[email protected]
Total Funding:
1.19 B CNY
Technology used in webpage:
Domain Not Resolving Euro Pound Sterling Japanese Yen Baidu Maps
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Exo Therapeutics
Exo Therapeutics is a small molecule drug discovery and development company.
MKBC
MKBC specializes in the integration of drug research and development.
Peroxitech Therapeutics
Peroxitech Therapeutics operates as a biopharmaceutical company.
Sciwind Biosciences
Sciwind Biosciences is a drug research and development company for metabolic diseases.
Silicon Therapeutics
Silicon Therapeutics is a fully integrated drug design, research, and development company.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Zeidman Pharmaceuticals
Zeidman Pharmaceuticals is a drug research and development company.
Current Employees Featured
Founder
Investors List
Changxing Financial Holdings
Changxing Financial Holdings investment in Series D - TYK Medicines
Huiyu Pharmaceutical
Huiyu Pharmaceutical investment in Series D - TYK Medicines
Houji Capital
Houji Capital investment in Series D - TYK Medicines
Huzhou Talent Fund
Huzhou Talent Fund investment in Series D - TYK Medicines
Zhejiang Silk Road Fund
Zhejiang Silk Road Fund investment in Venture Round - TYK Medicines
Zhejiang Silk Road Fund
Zhejiang Silk Road Fund investment in Series C - TYK Medicines
Zuig Investment
Zuig Investment investment in Series C - TYK Medicines
Houji capital
Houji capital investment in Series C - TYK Medicines
Yangtze River Industry Fund
Yangtze River Industry Fund investment in Series C - TYK Medicines
Wenzhou Capital
Wenzhou Capital investment in Series B - TYK Medicines
Official Site Inspections
http://www.tykmedicines.com
- Host name: 47.110.234.112
- IP address: 47.110.234.112
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "TYK Medicines"
同源康
上海同源康医药股份有限公司定位为一个国际化的创新生物技术高科技公司，立足中国，面向国际。公司专注于肿瘤靶向、肿瘤免疫治疗药物的研究开发，发展protac技术。公司的使命是集聚 …See details»
investor - tykmedicines.com
Investor. TYK Medicines is positioned as an international innovative biotechnology company, based in China with a global presence. The company focuses on the research and …See details»
公司简介 - tykmedicines.com
关于同源康. 同源康医药成立于2017年11月，在浙江湖州长兴生命科学园建立了30,000平方米新药研发中心，随后在上海建立了公司行政总部、临床医学部和商务拓展部，在郑州设立了小分子 …See details»
TYK Medicines - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 021-31317178 TYK Medicines, which has biological laboratories, cell culture laboratories, analysis laboratories, chemical analysis …See details»
TYK Medicines, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Www.tykmedicines.com. Startups | Public Company | 2017 | Zhejiang Sheng, China | 100-250 | HKG: 2410 | www.tykmedicines.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. ...See details»
Tyk Medicines, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Tyk Medicines, Inc. of Huzhou, Zhejiang. Get the latest business insights from Dun & Bradstreet.See details»
TYK Medicines Company Profile 2024: Stock …
TYK Medicines General Information Description. TYK Medicines Inc is a drug discovery research and development centre. The company and its subsidiaries are principally engaged in the research, development and commercialization …See details»
TYK Medicines - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
TYK Medicines - Overview, News & Similar companies - ZoomInfo
Www.tykmedicines.com. Revenue $49.6 Million. Industry Healthcare General Healthcare . Recent News & Media. No recent news or media. Overview ; Org Chart ; Who is TYK Medicines. TYK …See details»
TYK Medicines - Company Profile - Tracxn
Nov 21, 2024 TYK Medicines - Developer of drugs for the treatment of cancer. Public Company. Raised a total funding of $154M over 4 rounds from 13 investors. Founded by Wu Yusheng in …See details»
TYK Medicines - Products, Competitors, Financials, Employees ...
Tykmedicines.com. Overview & Products; Financials; Founded Year 2017. Stage IPO | IPO. Total Raised $182.1M. Date of IPO 8/20/2024. About TYK Medicines. TYK Medicines is a …See details»
TYK Medicines - Contacts, Employees, Board Members
TYK Medicines is a drug research and development company.See details»
TYK Medicines, Inc was Recognized as a New Type of Research …
Jan 1, 2022 Recently, the notice by the Science Technology Department of Zhejiang Province of issuing the List of New Types of Research and Development Institutions in 2021, TYK …See details»
TYK Medicines, Inc. (浙江同源康医药股份有限公司) - 药物管线_专 …
了解TYK Medicines, Inc. (浙江同源康医药股份有限公司)公司的药物管线，治疗领域，技术平台，以及它的24项临床试验, 150篇新闻和9篇文献，疾病领域:肿瘤，内分泌与代谢疾病，血液及 …See details»
TYK Medicines Stock Price, Funding, Valuation, Revenue
Aug 20, 2024 tykmedicines.com. Overview & Products; Financials; Total Raised $182.1M. Investors Count 21. Funding, Valuation & Revenue. 7 Fundings. TYK Medicines has raised …See details»
TYK Medicines, Inc (2410.HK) - Yahoo Finance
Find the latest TYK Medicines, Inc (2410.HK) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Series B - TYK Medicines - 2021-05-23 - Crunchbase
May 23, 2021 Organization Name . TYK Medicines . Announced Date May 23, 2021; Closed On Date May 23, 2021; Funding Type Series B; Funding Stage Early Stage Venture; Money …See details»
TYK Medicines raises $74M in HKEX IPO to launch EGFR inhibitor
Aug 20, 2024 TYK Medicines Inc. made a strong debut on the main board of the Hong Kong Stock Exchange (HKSE), raising HK$579 million (US$74.32 million) to commercialize its lead …See details»
TYK Medicines and WuXi STA Launch Comprehensive Strategic …
May 29, 2023 For more company information, please visit: www.tykmedicines.com About WuXi STA (Shanghai) Co., Ltd. WuXi STA, a subsidiary of WuXi AppTec, is an industry-leading …See details»
TYK Medicines collaborates with Syneos Health to conduct TY …
On May 27, 2022, TYK Medicines, Inc. announced a partnership with Syneos Health to conduct a Phase I clinical trial of TY-2136b in the United States.See details»